Brahim Aissani1, Kui Zhang2, Howard Wiener3. 1. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: baissani@uab.edu. 2. Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama. 3. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama.
Abstract
OBJECTIVE: To conduct a follow-up association mapping to independent genome-wide linkage and admixture mapping studies of uterine leiomyoma. DESIGN: Case-control, cross-sectional study. SETTING: Not applicable. PATIENT(S): A total of 1,045 premenopausal North American participants in the National Institute of Environmental Health Sciences Uterine Fibroid Study. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): We genotyped 2,772 single-nucleotide polymorphisms from candidate genes located in peaks of linkage (2q37, 3p21, 5p13, 10p11, 11p15, 12q14, and 17q25) or admixture linkage disequilibrium (2q37, 4p16.1, and 10q26) mapping and reported to have regulated expression in uterine fibroids. RESULT(S): We report significant associations of variant members of the collagen gene family with risk and tumor size, including missense variants in COL6A3 and COL13A, with replications in African American and European American study groups. Furthermore, the cell-matrix Rho GTPase-encoding ARHGAP26 gene, and MAN1C1, a gene encoding a Golgi mannosidase involved in the maturation of procollagens, emerged as new candidate uterine leiomyoma genes affecting both risk and tumor size. CONCLUSION(S): Our data converge onto a possible model of uterine leiomyoma pathogenesis resulting from altered regulation, maintenance, and/or renewal of the extracellular matrix.
RCT Entities:
OBJECTIVE: To conduct a follow-up association mapping to independent genome-wide linkage and admixture mapping studies of uterine leiomyoma. DESIGN: Case-control, cross-sectional study. SETTING: Not applicable. PATIENT(S): A total of 1,045 premenopausal North American participants in the National Institute of Environmental Health Sciences Uterine Fibroid Study. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): We genotyped 2,772 single-nucleotide polymorphisms from candidate genes located in peaks of linkage (2q37, 3p21, 5p13, 10p11, 11p15, 12q14, and 17q25) or admixture linkage disequilibrium (2q37, 4p16.1, and 10q26) mapping and reported to have regulated expression in uterine fibroids. RESULT(S): We report significant associations of variant members of the collagen gene family with risk and tumor size, including missense variants in COL6A3 and COL13A, with replications in African American and European American study groups. Furthermore, the cell-matrix Rho GTPase-encoding ARHGAP26 gene, and MAN1C1, a gene encoding a Golgi mannosidase involved in the maturation of procollagens, emerged as new candidate uterine leiomyoma genes affecting both risk and tumor size. CONCLUSION(S): Our data converge onto a possible model of uterine leiomyoma pathogenesis resulting from altered regulation, maintenance, and/or renewal of the extracellular matrix.
Authors: Michael W Smith; Nick Patterson; James A Lautenberger; Ann L Truelove; Gavin J McDonald; Alicja Waliszewska; Bailey D Kessing; Michael J Malasky; Charles Scafe; Ernest Le; Philip L De Jager; Andre A Mignault; Zeng Yi; Guy De The; Myron Essex; Jean-Louis Sankale; Jason H Moore; Kwabena Poku; John P Phair; James J Goedert; David Vlahov; Scott M Williams; Sarah A Tishkoff; Cheryl A Winkler; Francisco M De La Vega; Trevor Woodage; John J Sninsky; David A Hafler; David Altshuler; Dennis A Gilbert; Stephen J O'Brien; David Reich Journal: Am J Hum Genet Date: 2004-04-14 Impact factor: 11.025
Authors: Netta Mäkinen; Miika Mehine; Jaana Tolvanen; Eevi Kaasinen; Yilong Li; Heli J Lehtonen; Massimiliano Gentile; Jian Yan; Martin Enge; Minna Taipale; Mervi Aavikko; Riku Katainen; Elina Virolainen; Tom Böhling; Taru A Koski; Virpi Launonen; Jari Sjöberg; Jussi Taipale; Pia Vahteristo; Lauri A Aaltonen Journal: Science Date: 2011-08-25 Impact factor: 47.728
Authors: Donna Day Baird; David B Dunson; Michael C Hill; Deborah Cousins; Joel M Schectman Journal: Am J Obstet Gynecol Date: 2003-01 Impact factor: 8.661
Authors: Maija Kiuru; Rainer Lehtonen; Johanna Arola; Reijo Salovaara; Heikki Järvinen; Kristiina Aittomäki; Jari Sjöberg; Tapio Visakorpi; Sakari Knuutila; Jorma Isola; Brett Delahunt; Riitta Herva; Virpi Launonen; Auli Karhu; Lauri A Aaltonen Journal: Cancer Res Date: 2002-08-15 Impact factor: 12.701
Authors: Gary J Doherty; Monika K Åhlund; Mark T Howes; Björn Morén; Robert G Parton; Harvey T McMahon; Richard Lundmark Journal: Mol Biol Cell Date: 2011-09-30 Impact factor: 4.138
Authors: K T Barker; S Bevan; R Wang; Y-J Lu; A M Flanagan; J A Bridge; C Fisher; C J Finlayson; J Shipley; R S Houlston Journal: Br J Cancer Date: 2002-08-12 Impact factor: 7.640
Authors: Michael J Bray; Melissa F Wellons; Sarah H Jones; Eric S Torstenson; Todd L Edwards; Digna R Velez Edwards Journal: Fertil Steril Date: 2018-09 Impact factor: 7.490
Authors: Brahim Aissani; Kui Zhang; Arjen R Mensenkamp; Fred H Menko; Howard W Wiener Journal: Endocr Relat Cancer Date: 2015-06-25 Impact factor: 5.678
Authors: Jacklyn N Hellwege; Janina M Jeff; Lauren A Wise; C Scott Gallagher; Melissa Wellons; Katherine E Hartmann; Sarah F Jones; Eric S Torstenson; Scott Dickinson; Edward A Ruiz-Narváez; Nadin Rohland; Alexander Allen; David Reich; Arti Tandon; Bogdan Pasaniuc; Nicholas Mancuso; Hae Kyung Im; David A Hinds; Julie R Palmer; Lynn Rosenberg; Joshua C Denny; Dan M Roden; Elizabeth A Stewart; Cynthia C Morton; Eimear E Kenny; Todd L Edwards; Digna R Velez Edwards Journal: Hum Genet Date: 2017-08-23 Impact factor: 5.881
Authors: Michael J Bray; Todd L Edwards; Melissa F Wellons; Sarah H Jones; Katherine E Hartmann; Digna R Velez Edwards Journal: Fertil Steril Date: 2017-12 Impact factor: 7.490